ARKG is a Sector & Thematic ETF from ARK holding 32 positions as of Apr 30, 2026, with $1.6B in assets and a 0.75% net expense ratio. Its largest positions are TEM (9.4%), TWST (9.0%) and 1CG (8.9%); the top 10 holdings account for 58.8% of the portfolio.
- Issuer
- ARK
- Holdings
- 32
- Net Assets
- $1.6BETF assets as of 2026-08-10
- Expense Ratio
- 0.75%per latest SEC prospectus filing
- TTM Yield
- —
Performance
- 1M
- +1.0%
- YTD
- +48.6%
- 1Y
- +84.8%
- 3Y (ann.)
- +9.2%
- 5Y (ann.)
- -13.0%
- 10Y (ann.)
- +9.2%
A $10,000 investment 10 years ago would be worth $24,178 today at the 10Y annualized rate. This is a backward-looking illustration, not a forecast. Project its future growth →
Total returns including dividends as of 2026-08-07. 3Y/5Y/10Y annualized. Past performance does not predict future results.
Sector Breakdown
| Health Care | 93.3% |
|---|---|
| Other Sectors | 0.0% |
| Unclassified | 6.3% |
We could not classify 6% of portfolio weight. It is shown separately as “Unclassified”, not lumped into a sector.
Top 25 Holdings
| # | Holding | Weight |
|---|---|---|
| 1 |  TEMTempus AI, Inc., Class A | 9.42% |
| 2 |  TWSTTwist Bioscience Corporation COM | 8.99% |
| 3 |  1CGCRISPR Therapeutics AG COM CHF0.03 | 8.91% |
| 4 |  TXG10X Genomics, Inc., Class A | 5.77% |
| 5 |  BEAMBeam Therapeutics Inc. COM | 5.43% |
| 6 |  ABSIAbsci Corp. COM | 4.78% |
| 7 |  NTRANatera Inc. COM | 4.07% |
| 8 |  ILMNIllumina Inc COM | 4.03% |
| 9 |  NTLAIntellia Therapeutics Inc COM | 3.82% |
| 10 |  PSNLPersonalis, Inc. | 3.58% |
| 11 |  RXRXRecursion Pharmaceuticals, Inc., Class A | 3.51% |
| 12 |  GHGuardant Health Inc COM | 3.49% |
| 13 |  CDNACaredx Inc COM | 3.38% |
| 14 |  VCYTVeracyte Inc COM | 2.66% |
| 15 |  CMPSCompass Pathways plc | 2.43% |
| 16 |  ADPTAdaptive Biotechnologies Corp COM | 2.42% |
| 17 |  NRIXNurix Therapeutics Inc. COM | 2.33% |
| 18 |  WGSGeneDx Holdings Corp., Class A | 2.04% |
| 19 |  SDGRSchrodinger Inc/United States | 2.03% |
| 20 |  ARCTArcturus Therapeutics Holdings Inc COM | 1.96% |
| 21 |  BFLYButterfly Network, Inc., Class A | 1.89% |
| 22 |  IONSIonis Pharmaceuticals, Inc. COM | 1.74% |
| 23 |  ATAIAtaiBeckley, Inc. | 1.48% |
| 24 |  PRMEPrime Medicine Inc COM | 1.41% |
| 25 |  PACBPacific Biosciences Of California Inc. COM | 1.41% |
Showing the top 25 of 32 holdings. See the full ARKG holdings list →
ARKG alternatives
The closest Sector & Thematic ETFs to ARKG by portfolio overlap — the share of weight both funds hold in the same securities.
| Fund | Overlap | Expense | Assets | |
|---|---|---|---|---|
 ARKKARK Innovation ETF | 27% | 0.75% | $6.0B | Compare → |
 XBIState Street® SPDR® S&P® Biotech ETF | 9% | 0.35%cheaper | $10.0B | Compare → |
 IBBiShares Biotechnology ETF | 9% | 0.44%cheaper | $9.3B | Compare → |
 VHTVanguard Health Care Index Fund | 3% | 0.09%cheaper | $18.3B | Compare → |
| 3% | 0.08%cheaper | $3.3B | Compare → | |
 IYHiShares U.S. Healthcare ETF | 2% | 0.38%cheaper | $3.7B | Compare → |
 XTiShares Future Exponential Technologies ETF | 1% | 0.46%cheaper | $3.9B | Compare → |
 RSPHInvesco S&P 500 Equal Weight Health Care ETF | 1% | 0.4%cheaper | $776M | Compare → |
Frequently Asked Questions
What is ARKG's expense ratio?
ARKG has a net expense ratio of 0.75%, per its latest SEC prospectus filing. That works out to about $75 a year on a $10,000 investment.
How many holdings does ARKG have?
ARKG held 32 positions as of Apr 30, 2026, per its latest official holdings data.
What are ARKG's top 10 holdings?
ARKG's largest positions are TEM (9.4%), TWST (9.0%), 1CG (8.9%), TXG (5.8%), BEAM (5.4%), ABSI (4.8%), NTRA (4.1%), ILMN (4.0%), NTLA (3.8%), PSNL (3.6%). Together they account for 58.8% of the portfolio.
How big is ARKG?
ARKG has $1.6B in assets as of Aug 10, 2026.
What are good alternatives to ARKG?
By portfolio overlap, the closest Sector & Thematic ETFs to ARKG are ARKK (27% overlap), XBI (9% overlap), IBB (9% overlap). Overlap measures the share of portfolio weight both funds hold in the same securities.